{"name":"Ratio Therapeutics, Inc.","slug":"ratio-therapeutics-inc","ticker":"","exchange":"","domain":"ratio.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PTI-122","genericName":"PTI-122","slug":"pti-122","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"PTI-122","genericName":"PTI-122","slug":"pti-122","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPWnRCV2RZdDFHTkV5RjN2RHRDMjNOUjBEdWNHU25NQTdidmhhcnRTaDQzSnhQdEowYkY5NW1zMTY0MWxzZEZzeXU5eGhzSWpnbTk1OVFSMUR3M2tiYURNR3FoZFc0SlF1MWdReVNXaG9KaS1Ta3AweUw1X3AtODRLNExHR0Q4UDF6NG1pNXNxXzVfa1hnRFdaOGZpR1k1eWM4eVo3Q0p5TkZCTFR0YVpIaFUwalJWa0NCSnRCcUd0OEZfVFU0SDhhaDFJQUR1R1BuQ1V6Mk02VXpHcnBE?oc=5","date":"2026-03-12","type":"pipeline","source":"PR Newswire","summary":"Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer - PR Newswire","headline":"Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQemRXR0I5T3djekE2WVBEeDNqb0VJZXE5VWFNMWtPa0wzaDFXUE5Uc05XM1UxR0hJMV9KSUl6N0pJTG5Fcl9tUEk3Uk9fTWlPRVJEWlc5WlNTQjFEMFBZaXlPYTVVSHUzNjJUZExCUXd2a3lQcVRIeXhHZE9tVXBMT0toaWhTQTZRYi1ieFVjZXRhWkNPNktCQ0NLRi10Vmc?oc=5","date":"2026-03-12","type":"pipeline","source":"Pharmaceutical Online","summary":"Raising The Bar In Radiopharmaceutical Manufacturing - Pharmaceutical Online","headline":"Raising The Bar In Radiopharmaceutical Manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxOM2czT0JGX3ktazY0Rmh0S1dEam04R3FERGdybTZOWThRRkFOT2NKdE1obEx4Wl9leHd6MVJCcFJac01UZ3gxOHVFTkcxYzNKQ1RySEFibWZwZzZQUFBlTTZDdmRjWnUyZld3ZUdkTFBKeS1PaE9TX1JhTHYzQXhXQ0owanBGVUVqVC1WYmhtT3EydEJLOHVLLUdoa3FWS1p1cjl0RFU2NzdpX3FWc0FUTDhiX1lLUnZGSC0xRFRhSXJBeGlyd280YVlfRVVyNEpMY01iaEtDSTVOVDhOUm1zUEpTUEV5STRGWlUwc1IxQzFLWFNwdDlHRk1qd3A3WThOODhBMFBCQmdpU3JyRmZSSXoxemVGYXo1UVFBc0lRSkkzanF0cE0yUElVRHhCR2tCd2E0dHcxZExLUHBqMTJ6NmFDYTF3Y2FOT3dfcHo3dkpSejNBb2Q4?oc=5","date":"2025-12-16","type":"trial","source":"PR Newswire","summary":"Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas - PR Newswire","headline":"Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiop","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxOQlJpMEs1dUVMQ0dza1dWX2VEUjFQU1JIeDF4ZDExZGtzQ3luU0ZOTGtnaTBfQmVJWWphSUU3ckNhV1JoQjQxQzZzdk8wbkliX0xEQ3haQXhjTWlRczhxWXVtc2Voa1R0YkxLeElQbjJNZWY3MjdVdmpIemk5TVBjNFFfXzViTnlyUnNRZWtrZWVqSm1sbHBUczdqbVpVN1JBVXNXTUg3emJERGlaZmRMRllsNGhPbzhod2hvZDRYdlRZajdwTkVqVkxUQ0twTkt0ZGZXQXRHV1BqbnZxdnRydVY5eE5weUFwbWhQQnNuOXNNWmxHdTk0X3o1NFJWQmJhX1N6Rlcwb2p3cHRCaVlFSk8wUTdQMVU3RWxBTlBsX1lRN3N6eXB4VXlwQUtTVV84TEZ5OHl2Tm9RYkk3T2owbFZsS3dIa2JQUDRYeXRMRjFReTZ3?oc=5","date":"2025-12-16","type":"trial","source":"PR Newswire","summary":"PharmaLogic Announces Successful Supply of First Cohort Dosing for Ratio Therapeutics' Phase 1/2 Study of a Novel FAP-Targeted Radiopharmaceutical in Late-Stage Aggressive Sarcomas - PR Newswire","headline":"PharmaLogic Announces Successful Supply of First Cohort Dosing for Ratio Therapeutics' Phase 1/2 Study of a Novel FAP-Ta","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOTTg5QlVhTVJrUS02RlRqTkFmLTZEdHBzOHRKYnB6bnNzZXZHV2ZjaHlHSEkzZGNFZEhHYzFRYkQyRlNpMUc5ejlkU2FsVHZKUnp6cHEtdk43UGJvSWpaTXZqZC1IUk9pb3Y4UFVlMkVqd1hMY1ZES1RFdUVtNHRSYWtSdzlsZXFGN3pYcXNLcVc0RTRMbkJQVTdCemNyU2kydjVsc2QxMTZfZms?oc=5","date":"2025-11-04","type":"pipeline","source":"citybiz","summary":"Ratio Therapeutics Appoints Marcel Reichen as Chief Strategy Officer - citybiz","headline":"Ratio Therapeutics Appoints Marcel Reichen as Chief Strategy Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOd3VVaWcxaWZTWlBhT3RyQ0dnSXU1WjhMWGZqVkNPb19JeTFGdzdmZkJDMWxjSlV6VXM2UXZaZFFFeUgwdkdpaHc3ZW9SQy1CeDJUdkFXN0xWMlZOTXR6OXRZcnJWdTYzREwwS0VESjVzNVlxMGptSzlDSF9SQ19nVW1QbkFCNUFka2NoRENSdkJlSnlIdmxLakdpMmZ5elk1YWJzQi1WRUZ5Q1BoQ2pxQlNOT1pqd19qcnowalV6TExiQXhNelVnU3pta0hhX09Oc1lXNlQ0OU9KT2hjaEJxMHViODZ4MUhSbkRmSDdfMlgxaExfYjRzX1VHVjE?oc=5","date":"2025-06-20","type":"pipeline","source":"PR Newswire","summary":"Ratio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted Radiotherapeutics - PR Newswire","headline":"Ratio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted Radiotherapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNRlJiZThPS1Z4WVhBSnE2aHVfNnc5VGxHNndaRkVwZjdMcjJYLUYtV0FCQUg0S0dGNEJYMk5QUTVSTzV6UlF1Y0tpMVNFeHBQVXZDUlh5Mk55QXMzazV5cTlCSUpKT2QxTk1jV0tXU3FxYkh4cS1tZVJyWExyb2dWei1UQzdtby1ZWkFkNUdZR3V1Ql9lS0ludU9uaGRiZWNlTXBFWjhGSEQ5Skx6eXlEOWVtaDdMV0pBVWJmMFJBUEtYakYta3ZOTDN6T05hYWJZZHdUbjJIb0VUbk1BZkFuRmNqN2ZUbXBtMTgwYjJYR2JSS3dWZnFUNTlQRG54NWZob1piZFpIa0Itd25sM081Sg?oc=5","date":"2025-06-17","type":"pipeline","source":"PR Newswire","summary":"Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals - PR Newswire","headline":"Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmac","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxQM0MySnFGd3ZLTzItODd2NUxxZk0tNHZCUXdFVkUyd0tWczZNWWFoN1IwNG1PekdibklhQ1hIcVFlSWlhYUxJRDZabmlDME1oekNFNW9fUmZDcGNyS0xVVm9jSzVKVHdSOXR3eEhqX2NPNGRPaVJRd1ZKNnBPWWN3ME1qdnN3djQ3djVfaFplZXFkSmhQeTdwRHplLWlnNDhPdFdIb3lkOXBmMEVqVTBrTk16QWNJbFp2QnhjTjEyeU56bUR6eTdZcXUxdkNLZTJFb21wdy1sUEVIZmV6Ykg0QlRERzNsUHc0YTZWX2JNdUxjVVV3anR3U3hkN3duRmJwTFRvN1J4LVdnU1d5ZktWaEMzOGstejhkc2JF?oc=5","date":"2025-06-13","type":"deal","source":"PR Newswire","summary":"Ratio Therapeutics Partners with Macrocyclics for Exclusive Manufacturing and Distribution of its Radiopharmaceutical Chelator Platform - PR Newswire","headline":"Ratio Therapeutics Partners with Macrocyclics for Exclusive Manufacturing and Distribution of its Radiopharmaceutical Ch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQYnRmNl9OUzVzVnNtNHB2djgybU9GYUxUWVlacVppUEhjdWc0dHdLR2VPUVhpbzcxX3U5bXZRZEZVbU10anNCWTRiM3EtTnVCN1FBUC01N2pFOXB6TWJBcEwxLU5UZ2JJQUUtOXpLS1QzNFN4U1JnN0JoMjFULXk0SFZaNnlWaFF3cGx1Q25SZXN1RlMzOEtXYV9GcGlRZEhGekRVRVpTYzBJMDg?oc=5","date":"2025-05-13","type":"deal","source":"Fierce Pharma","summary":"Ratio inks deal to build radiopharmaceutical R&D, manufacturing facility in Utah - Fierce Pharma","headline":"Ratio inks deal to build radiopharmaceutical R&D, manufacturing facility in Utah","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOTkRpT25UdU1oc2QtVDN3NVRrUEZSVFJRX1V0Qnp0bFZuZ1l6TEpmeE1RSkFuN1pYMm5zalMta052ajJ1VEptVkxyTHFzaGJmY181WmcyYzV6RGl5QmhGTUE5RUtXanR0cEItU1JTbTQ3a3o4OFpwOFAyckhybUpIV0FsUHVZTl9fNVhYMGdpSjgtcXE0OU56d09ucGxIZkY3NWpPbGpFVmNYSWRSMDJqbDRKRFFCbVI2NmNUbV8zTTgyV2JK?oc=5","date":"2025-05-12","type":"pipeline","source":"Contract Pharma","summary":"Ratio Therapeutics to Build a Radiopharmaceutical Manufacturing Facility in Utah - Contract Pharma","headline":"Ratio Therapeutics to Build a Radiopharmaceutical Manufacturing Facility in Utah","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQbGlDc2ZOTGNVeHZOMFBkZEZRVkRxVjYwNG81SXRpdXR3WkIxTDB4b3I0bFlndklhNWxZckpCeFNvTTZvMEtYNzdYeXE2SVRMTGRPd3ZlM25NSW1mUHF1MWRKM0RHU0JtOUtpcFViYzlCVTBtVTQ1djhTVFZkM2JEYkZHUE9GQlZkSEpMOU1fYUFxSjNqUnFSVGlSU0RHQWQ1NzlWR1VHVGlyVFlFWTBkcVNseTNENU5RaTRUczlXbjZZek5DTlJLQUl3azJRUDA?oc=5","date":"2025-05-08","type":"pipeline","source":"PR Newswire","summary":"Ratio Therapeutics to Establish New Radiopharmaceutical Manufacturing Facility - PR Newswire","headline":"Ratio Therapeutics to Establish New Radiopharmaceutical Manufacturing Facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOWkhNbm1Na2ZHYUg5Nk4tOW1JaWhKRXRURjJneEYyUGtEYlVacmlmMVpPVEN2YUlLM1NoNzZzTWRadjVEMXpKTU92WEZubEFva2ZsbmtjWk5yUTYwT1FqZDc2eXEtRXYzczBMZGNySE80aE1aVWlhVWhxc2pNUE02aXdpcWtwSFpENFBVRXRrT0Ezd2hvMmd3bEV0SWdMTk13UW12b1J4Nk56ZFV1a1d3SkJmRTlRNzNuVzJlWA?oc=5","date":"2024-11-19","type":"deal","source":"Pharmaceutical Technology","summary":"Novartis strengthens radiopharma leadership with Ratio Therapeutics deal - Pharmaceutical Technology","headline":"Novartis strengthens radiopharma leadership with Ratio Therapeutics deal","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}